Price T Rowe Associates Inc Dice Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $82.5 Million - $149 Million	-3,190,981 Reduced 98.02%	64,449 $3 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $923,993 - $1.15 Million	35,470 Added 1.1%	3,255,430 $93.3 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $13.2 Million - $28.1 Million	666,503 Added 26.1%	3,219,960 $100 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2.08 Million - $3.14 Million	138,833 Added 5.75%	2,553,457 $51.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $3.57 Million - $5.99 Million	270,940 Added 12.64%	2,414,624 $37.5 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $5.68 Million - $9.78 Million	390,893 Added 22.3%	2,143,684 $41 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $5.61 Million - $9.41 Million	250,542 Added 16.68%	1,752,791 $44.4 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $48 Million - $55.6 Million	1,502,249 New	1,502,249 $49.2 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.